Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ Opsin Blue Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA578371
Description
Predicted Reactivity: Human (100%), Chimpanzee (100%) Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
Opsin Blue belongs to the G-protein coupled receptor 1 family, opsin subfamily. It encodes the blue cone pigment gene which is one of three types of cone photoreceptors responsible for normal color vision. Defects in this gene are the cause of tritan color blindness (tritanopia). Affected individuals lack blue and yellow sensory mechanisms while retaining those for red and green. Defective blue vision is characteristic.
Specifications
Opsin Blue | |
Polyclonal | |
Unconjugated | |
OPN1SW | |
AW551857; BCP; blue cone opsin; blue cone opsin-like pigment; blue cone photoreceptor pigment; blue cone pigment; blue opsin; blue/UV opsin; blue-sensitive opsin; BOP; CBT; OPN1SW; opsin 1 (cone pigments), short-wave-sensitive; opsin 1 (cone pigments), short-wave-sensitive (color blindness, tritan); s opsin; short wavelength sensitive opsin; short wavelength-sensitive cone opsin; Short-wave-sensitive opsin 1; SWS opsin; UV cone pigment | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
12057, 611 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot | |
1.6 mg/mL | |
PBS with 20% glycerol and 0.025% ProClin 300; pH 7 | |
P03999, P51491 | |
OPN1SW | |
Carrier-protein conjugated synthetic peptide encompassing a sequence within the N-terminus region of Human OPN1SW. The exact sequence is proprietary. | |
100 μL | |
Primary | |
Human, Mouse | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction